ICICI Direct has recommended a ‘Buy' on the scrip of IPCA Laboratories for 12 months period with a target price of Rs. 2490. This implies an upside of 20.69 percent from the current price level of Rs. 2063 per share.
from Tax Saving Investments | Tax Saving Tips & News | Income Tax India – Oneindia Money https://ift.tt/3oWERZh
via IFTTT
from Tax Saving Investments | Tax Saving Tips & News | Income Tax India – Oneindia Money https://ift.tt/3oWERZh
via IFTTT